Medytox, Inc. Announces the Formation of Luvantas Subsidiary and Appointment of Key Executives
IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. ( www.luvantas.com ) as its wholly-owned North American subsidiary.
- IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ -- Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. ( www.luvantas.com ) as its wholly-owned North American subsidiary.
- More information on this state-of-the-art formulation of Botulinum toxin will be provided once regulatory approvals are obtained.
- In connection with the formation of Luvantas, Thomas A. Albright has been appointed its President and CEO and Stephanie A. Yee has been appointed its CFO.
- As CEO, Tom brings 40 years of healthcare experience to Luvantas with medical aesthetic leadership roles since 2000.